A detailed history of Next Level Private LLC transactions in Pfizer Inc stock. As of the latest transaction made, Next Level Private LLC holds 58,178 shares of PFE stock, worth $1.66 Million. This represents 0.73% of its overall portfolio holdings.

Number of Shares
58,178
Previous 53,944 7.85%
Holding current value
$1.66 Million
Previous $1.51 Million 11.53%
% of portfolio
0.73%
Previous 0.72%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$27.7 - $31.39 $117,281 - $132,905
4,234 Added 7.85%
58,178 $1.68 Million
Q2 2024

Aug 01, 2024

BUY
$25.26 - $29.6 $6,693 - $7,844
265 Added 0.49%
53,944 $1.51 Million
Q1 2024

Apr 15, 2024

SELL
$25.89 - $29.73 $2,407 - $2,764
-93 Reduced 0.17%
53,679 $1.49 Million
Q4 2023

Jan 18, 2024

BUY
$26.13 - $33.94 $162,371 - $210,903
6,214 Added 13.07%
53,772 $1.55 Million
Q3 2023

Oct 10, 2023

BUY
$32.09 - $37.51 $2,310 - $2,700
72 Added 0.15%
47,558 $1.58 Million
Q2 2023

Jul 14, 2023

BUY
$36.12 - $41.79 $2,420 - $2,799
67 Added 0.14%
47,486 $1.74 Million
Q1 2023

Apr 10, 2023

SELL
$39.39 - $51.28 $118 - $153
-3 Reduced 0.01%
47,419 $1.93 Million
Q4 2022

Jan 26, 2023

SELL
$41.75 - $54.5 $9,352 - $12,208
-224 Reduced 0.47%
47,422 $0
Q3 2022

Oct 21, 2022

BUY
$43.76 - $53.42 $345,222 - $421,430
7,889 Added 19.84%
47,646 $2.1 Million
Q2 2022

Aug 09, 2022

SELL
$46.53 - $55.17 $372,379 - $441,525
-8,003 Reduced 16.76%
39,757 $2.08 Million
Q1 2022

May 05, 2022

BUY
$45.75 - $56.69 $16,012 - $19,841
350 Added 0.74%
47,760 $2.47 Million
Q4 2021

Feb 11, 2022

BUY
$41.32 - $61.25 $1.96 Million - $2.9 Million
47,410 New
47,410 $2.8 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $160B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Next Level Private LLC Portfolio

Follow Next Level Private LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Next Level Private LLC, based on Form 13F filings with the SEC.

News

Stay updated on Next Level Private LLC with notifications on news.